LANSEN PHARMAC.HLD.DL-,01

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2021, LANSEN PHARMAC.HLD.DL-,01 has already paid €0.16 in dividends. The last payout was in September 2021.

Financials

In the last year, LANSEN PHARMAC.HLD.DL-,01 had revenue of €61.12M and net profit of €8.01M

(EUR)	2022	YoY
Revenue	61.12M	28.27%
Gross profit	41.29M	36.47%
Net profit	8.01M	909.27%
EBITDA	14.22M	38.72%

Fundamentals

Metric	Value
Market capitalization	€85.62M
Number of shares	419.33M
52-week high/low	€0.21 - €0.14
Dividends	No
Beta	0.92
P/E ratio	11.13
PEG ratio	0.11
P/B ratio	0.79
P/S ratio	1.46

Company profile

Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.